Kolinpharma Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 2/6
Kolinpharma has been growing earnings at an average annual rate of 24.9%, while the Personal Products industry saw earnings growing at 13.6% annually. Revenues have been growing at an average rate of 16.1% per year. Kolinpharma's return on equity is 4.1%, and it has net margins of 2.2%.
Wichtige Informationen
24.9%
Wachstumsrate der Gewinne
23.3%
EPS-Wachstumsrate
| Personal Products Wachstum der Industrie | 13.6% |
| Wachstumsrate der Einnahmen | 16.1% |
| Eigenkapitalrendite | 4.1% |
| Netto-Marge | 2.2% |
| Letzte Ertragsaktualisierung | 31 Dec 2022 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Kolinpharma (BIT:KIP) Is Looking To Continue Growing Its Returns On Capital
Jun 17
What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Dec 01An Intrinsic Calculation For Kolinpharma S.p.A. (BIT:KIP) Suggests It's 46% Undervalued
Aug 25We Think Kolinpharma (BIT:KIP) Can Stay On Top Of Its Debt
Jun 08Do Kolinpharma's (BIT:KIP) Earnings Warrant Your Attention?
May 21Is There An Opportunity With Kolinpharma S.p.A.'s (BIT:KIP) 35% Undervaluation?
May 03Some Shareholders Feeling Restless Over Kolinpharma S.p.A.'s (BIT:KIP) P/E Ratio
Apr 13What Does Kolinpharma S.p.A.'s (BIT:KIP) Share Price Indicate?
Feb 20Is Weakness In Kolinpharma S.p.A. (BIT:KIP) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Dec 28These 4 Measures Indicate That Kolinpharma (BIT:KIP) Is Using Debt Reasonably Well
Nov 22Aufschlüsselung der Einnahmen und Ausgaben
Wie Kolinpharma Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Dec 22 | 16 | 0 | 5 | 0 |
| 30 Sep 22 | 14 | 0 | 5 | 0 |
| 30 Jun 22 | 13 | 0 | 5 | 0 |
| 31 Mar 22 | 13 | 0 | 5 | 0 |
| 31 Dec 21 | 13 | 1 | 5 | 0 |
| 30 Sep 21 | 13 | 1 | 4 | 0 |
| 30 Jun 21 | 13 | 1 | 4 | 0 |
| 31 Mar 21 | 11 | 1 | 3 | 0 |
| 31 Dec 20 | 10 | 1 | 3 | 0 |
| 30 Sep 20 | 9 | 1 | 3 | 0 |
| 30 Jun 20 | 9 | 1 | 3 | 0 |
| 31 Mar 20 | 10 | 1 | 3 | 0 |
| 31 Dec 19 | 10 | 1 | 3 | 0 |
| 30 Sep 19 | 10 | 0 | 3 | 0 |
| 30 Jun 19 | 9 | 0 | 2 | 0 |
| 31 Mar 19 | 9 | 0 | 2 | 0 |
| 31 Dec 18 | 9 | 0 | 2 | 0 |
| 30 Sep 18 | 8 | 0 | 0 | 0 |
| 30 Jun 18 | 7 | 0 | 1 | 0 |
| 31 Mar 18 | 6 | 0 | 1 | 0 |
| 31 Dec 17 | 5 | 0 | 1 | 0 |
| 31 Dec 16 | 4 | 0 | 0 | 0 |
| 31 Dec 15 | 2 | -1 | 1 | 0 |
Qualität der Erträge: KIP has high quality earnings.
Wachsende Gewinnspanne: KIP's current net profit margins (2.2%) are lower than last year (5%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: KIP has become profitable over the past 5 years, growing earnings by 24.9% per year.
Beschleunigtes Wachstum: KIP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: KIP had negative earnings growth (-46.3%) over the past year, making it difficult to compare to the Personal Products industry average (-25.1%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: KIP's Return on Equity (4.1%) is considered low.